Suppr超能文献

[合成抗甲状腺药物治疗格雷夫斯病的预后演变(作者译)]

[Prognostic evolution of Graves' disease treated by synthetic antithyroid (author's transl)].

作者信息

Leclere J, Hartemann P, Heimfert C, Ueda M

出版信息

Ann Endocrinol (Paris). 1980 Nov-Dec;41(6):581-4.

PMID:6166241
Abstract

A follow-up of at least 4 years after withdrawal of a medical treatment of 77 patients with Graves' disease is presented. The treatment consisted in Carbimazole (15-30 mg/d), LT3 (75 ug/d), Propranolol (30-60 mg/d), Hydroxyzine (75 mg/d). A normal thyroid suppressibility (20 mm 99m Tc uptake test) is obtained in patients without goiter faster than in those with goiter. A normal early uptake at the sixth month therapy is a good index for cure. Despite this result the authors recommend a treatment of 12 to 18 months duration because of the probable immunodepressive effect of the antithyroid drugs.

摘要

本文介绍了77例格雷夫斯病患者停止药物治疗后至少4年的随访情况。治疗方案包括卡比马唑(15 - 30毫克/天)、左甲状腺素钠(75微克/天)、普萘洛尔(30 - 60毫克/天)、羟嗪(75毫克/天)。无甲状腺肿的患者比有甲状腺肿的患者更快获得正常的甲状腺抑制性(20毫米99m锝摄取试验)。治疗6个月时早期摄取正常是治愈的良好指标。尽管有此结果,但由于抗甲状腺药物可能存在免疫抑制作用,作者仍建议进行12至18个月的治疗。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验